SCOPE: Systemic inflammation, endothelial dysfunction, and oxidative stress are involved in the pathogenesis of the metabolic syndrome (MetS). Epidemiological evidence supports an association between whole soy food consumption and reduced risk of cardiovascular disease (CVD). The objective of this randomized, controlled, cross-over study was to evaluate the effects of soy nut consumption on inflammatory biomarkers and endothelial function and to assess whether isoflavone metabolism to secondary products, equol, and/or O-desmethylangolensin (ODMA), modifies these responses. METHODS AND RESULTS:n = 17 adults at cardiometabolic risk were randomly assigned to the order of two snack interventions, soy nuts, and macronutrient-matched control snack, for four weeks each, separated by a two week washout period. Outcome measures included biomarkers of inflammation, oxidative stress, and glycemic control (ELISA and clinical analyzers), endothelial function, and arterial stiffness (peripheral arterial tonometry (PAT)), and isoflavone metabolites (LC-MS/MS). Results revealed that consuming soy nuts improved arterial stiffness as assessed by the augmentation index using PAT (p = 0.03), despite lack of improvement in inflammatory biomarkers. Addition of equol and/or ODMA production status as covariates did not significantly change these results. CONCLUSION:Soy nuts when added to a usual diet for one month provide some benefit on arterial stiffness in adults at cardiometabolic risk.
RCT Entities:
SCOPE: Systemic inflammation, endothelial dysfunction, and oxidative stress are involved in the pathogenesis of the metabolic syndrome (MetS). Epidemiological evidence supports an association between whole soy food consumption and reduced risk of cardiovascular disease (CVD). The objective of this randomized, controlled, cross-over study was to evaluate the effects of soy nut consumption on inflammatory biomarkers and endothelial function and to assess whether isoflavone metabolism to secondary products, equol, and/or O-desmethylangolensin (ODMA), modifies these responses. METHODS AND RESULTS: n = 17 adults at cardiometabolic risk were randomly assigned to the order of two snack interventions, soy nuts, and macronutrient-matched control snack, for four weeks each, separated by a two week washout period. Outcome measures included biomarkers of inflammation, oxidative stress, and glycemic control (ELISA and clinical analyzers), endothelial function, and arterial stiffness (peripheral arterial tonometry (PAT)), and isoflavone metabolites (LC-MS/MS). Results revealed that consuming soy nuts improved arterial stiffness as assessed by the augmentation index using PAT (p = 0.03), despite lack of improvement in inflammatory biomarkers. Addition of equol and/or ODMA production status as covariates did not significantly change these results. CONCLUSION: Soy nuts when added to a usual diet for one month provide some benefit on arterial stiffness in adults at cardiometabolic risk.
Authors: Liza Valentín-Blasini; Melissa A Sadowski; Donna Walden; Lisa Caltabiano; Larry L Needham; Dana B Barr Journal: J Expo Anal Environ Epidemiol Date: 2005-11
Authors: Vera van der Velpen; Anouk Geelen; Evert G Schouten; Peter C Hollman; Lydia A Afman; Pieter van 't Veer Journal: J Nutr Date: 2013-04-24 Impact factor: 4.798
Authors: Leila Azadbakht; Masoud Kimiagar; Yadollah Mehrabi; Ahmad Esmaillzadeh; Frank B Hu; Walter C Willett Journal: Br J Nutr Date: 2007-05-17 Impact factor: 3.718
Authors: Peter Celec; Július Hodosy; Roland Pálffy; Roman Gardlík; Lukáč Halčák; Daniela Ostatníková Journal: Molecules Date: 2013-05-07 Impact factor: 4.411
Authors: April J Stull; Katherine C Cash; Catherine M Champagne; Alok K Gupta; Raymond Boston; Robbie A Beyl; William D Johnson; William T Cefalu Journal: Nutrients Date: 2015-05-27 Impact factor: 5.717